Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision label was updated from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T01:43:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the AMEERA-5 breast cancer study is available, including its terminated status, study design and outcomes, eligibility criteria, locations, and linked study documents.
    Difference
    100%
    Check dated 2026-11-10T22:59:36.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:10:04.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision number changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:31:04.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:43:09.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previously visible study record details with a basic error layout and a Home link. This indicates the page is inaccessible.
    Difference
    18%
    Check dated 2026-09-22T23:33:22.000Z thumbnail image

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.